Order byBest matchMost fresh

COVID-19, FDA and Vaccine

Digest more
FDA Officials Detail Plan to Limit COVID Shots
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 and up, along with people ages 12 and up who have at least one underlying condition that puts them at risk of severe disease.

Continue reading

Health News Florida · 2h
A stricter FDA policy for COVID vaccines could limit future access
Novavax Shares Jump After Long-Awaited FDA Approval of Its COVID-19 Vaccine
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

Continue reading

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved
US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved
FDA sets new COVID booster guidelines for healthy adults under 65
Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

Continue reading

F.D.A. Poised to Restrict Access to Covid Vaccines
FDA to limit future Covid-19 shots to older people and those at risk of serious infection
Green Matters on MSN7d
COVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects Revealed
A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety of the COVID-19 vaccine?
AARP1d
Third COVID Vaccine Gets Approved for Adults 65 and Over
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
Business Times5h
FDA Moves to Restrict COVID Vaccine Access for Healthy Adults and Children, Requiring New Clinical Trials
The Food and Drug Administration announced sweeping changes to its COVID-19 vaccine policy Tuesday, signaling a major departure from universal booster recommendations and shifting toward targeted protection for high-risk populations.
McKnight's Long-Term Care News6d
Single-shot vaccine protects seniors from both flu and COVID-19 in clinical trial
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a phase 3 clinical trial published May 7 in JAMA.
News-Medical.Net on MSN11d
Oxford study reveals how COVID-19 vaccines prevent severe illness
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
Politico4d
FDA’s Makary: Covid shot guidance coming soon
More public events coming: Makary disclosed plans to hold public roundtables on cosmetics and drug regulation issues ... rethink the science around Covid vaccine efficacy now that the virus ...
CIDRAP12d
Excess weight in long-COVID patients linked to neurologic symptoms
Overweight and obesity were significantly associated with memory issues and persistent headache, among other conditions.
Feedback